Literature DB >> 26874835

Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series.

Luca Pasina1, Danilo Zanotta2, Silvana Puricelli2, Guido Bonoldi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26874835     DOI： 10.1007/s00228-016-2024-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  Proton pump inhibitors and risk of hypomagnesemia.

Authors:  Luca Pasina; Danilo Zanotta; Silvana Puricelli; Djade Codjo Djignefa; Guido Bonoldi
Journal:  Eur J Intern Med       Date:  2015-07-09       Impact factor: 4.487

2.  Severe acute neurological symptoms related to proton pump inhibitors induced hypomagnesemia responsible for profound hypoparathyroidism with hypocalcemia.

Authors:  Alban Deroux; Charles Khouri; Olivier Chabre; Laurence Bouillet; Olivier Casez
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-04-13       Impact factor: 2.947

3.  A case series of proton pump inhibitor-induced hypomagnesemia.

Authors:  Ewout J Hoorn; Joost van der Hoek; Rob A de Man; Ernst J Kuipers; Clemens Bolwerk; Robert Zietse
Journal:  Am J Kidney Dis       Date:  2010-02-26       Impact factor: 8.860

4.  Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.

Authors:  Tania Weber Furlanetto; Gustavo Adolpho Moreira Faulhaber
Journal:  Arch Intern Med       Date:  2011-05-09

Review 5.  Proton pump inhibitors and severe hypomagnesaemia.

Authors:  Tim Cundy; Jonathan Mackay
Journal:  Curr Opin Gastroenterol       Date:  2011-03       Impact factor: 3.287

Review 6.  The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.

Authors:  Chan Hyuk Park; Eun Hye Kim; Yun Ho Roh; Ha Yan Kim; Sang Kil Lee
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

7.  Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.

Authors:  Jonathan Zipursky; Erin M Macdonald; Simon Hollands; Tara Gomes; Muhammad M Mamdani; J Michael Paterson; Nina Lathia; David N Juurlink
Journal:  PLoS Med       Date:  2014-09-30       Impact factor: 11.069

8.  Mood disorder as a manifestation of primary hypoparathyroidism: a case report.

Authors:  Regis G Rosa; Alcina J S Barros; Antonio R B de Lima; William Lorenzi; Rafael R Da Rosa; Karine D Zambonato; Gustavo V Alves
Journal:  J Med Case Rep       Date:  2014-10-03
  8 in total
  5 in total

1.  Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor.

Authors:  Luca Pasina; Danilo Zanotta; Silvana Puricelli; Guido Bonoldi
Journal:  Eur J Clin Pharmacol       Date:  2016-11-28       Impact factor: 2.953

Review 2.  Genetics of Magnesium Disorders.

Authors:  Heng Li; Shiren Sun; Jianghua Chen; Goushuang Xu; Hanmin Wang; Qi Qian
Journal:  Kidney Dis (Basel)       Date:  2017-07-05

3.  Posterior Reversible Encephalopathy Syndrome due to Hypomagnesemia: A Case Report and Literature Review.

Authors:  Mohamad Almoussa; Angelika Goertzen; Stephan Brauckmann; Barbara Fauser; Christoph W Zimmermann
Journal:  Case Rep Med       Date:  2018-11-29

Review 4.  Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences.

Authors:  Gloria Ortiz-Guerrero; Diana Amador-Muñoz; Carlos Alberto Calderón-Ospina; Daniel López-Fuentes; Mauricio Orlando Nava Mesa
Journal:  Neural Plast       Date:  2018-03-21       Impact factor: 3.599

5.  The Janus-like Association between Proton Pump Inhibitors and Dementia.

Authors:  Anna Papazoglou; Muhammad I Arshaad; Christina Henseler; Johanna Daubner; Karl Broich; Britta Haenisch; Marco Weiergräber
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.